1790 G/A polymorphism, but not 1772 C/T polymorphism, is significantly associated with Cancers: An update study

Gene

Volumn 523, Issue 1, 2013, Pages 58-63

  Liu, Jie ^a   Zhang, Hong xin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; CI; Genetic polymorphism; HIF 1 ; Hif 1 ; HWE; Meta analysis; OR; SNP

Indexed keywords

ALLELE; ARTICLE; COLORECTAL CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ALLELES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NUCLEOTIDES; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84877813181     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.129     Document Type: Article

References (55)

1. Apaydin I., Konac E., Onen H.I., Akbaba M., Tekin E., Ekmekci A. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. Arch. Med. Res. 2008, 39:338-345.
2. Bos R., et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 2001, 93:309-314.
3. Brahimi-Horn M.C., Pouyssegur J. HIF at a glance. J. Cell Sci. 2009, 122:1055-1057.
4. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia and cancer. J. Mol. Med. 2007, 85:1301-1307.
5. Chan N., Koch C.J., Bristow R.G. Tumor hypoxia as a modifier of DNA strand break and cross-link repair. Curr. Mol. Med. 2009, 9:401-410.
6. Chau C.H., et al. Polymorphism in the hypoxia-inducible factor 1 alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol. Ther. 2005, 4:1222-1225.
7. Chen M.K., et al. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol. 2009, 45:222-226.
8. Cheung W.Y., Liu G. Genetic variations in esophageal cancer risk and prognosis. Gastroenterol. Clin. N. Am. 2009, 38:75-91.
9. Clifford S.C., Astuti D., Hooper L., Maxwell P.H., Ratcliffe P.J., Maher E.R. The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma. Oncogene 2001, 20:5067-5074.
10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
11. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
12. Foley R., et al. The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol. Ther. 2009, 8:118-124.
13. Frank B., Hoffmeister M., Klopp N., Illig T., Chang-Claude J., Brenner H. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis 2010, 31:1381-1386.
14. Fransén K., Fenech M., Fredrikson M., Dabrosin C., Söderkvist P. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol. Carcinog. 2006, 45:833-840.
15. Gardner M., Gonzalez-Neira A., Lao O., Calafell F., Bertranpetit J., Comas D. Extreme population differences across neuregulin 1 gene, with implications for association studies. Mol. Psychiatry 2006, 11:66-75.
16. Horrée N., Groot A.J., van Hattem W.A., Heintz A.P., Vooijs M., van Diest P.J. HIF-1A gene mutations associated with higher microvessel density in endometrial carcinomas. Histopathology 2008, 52:637-639.
17. Hsiao P.C., et al. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J. Surg. Oncol. 2010, 102:163-169.
18. Huang L.E., Bindra R.S., Glazer P.M., Harris A.L. Hypoxia-induced genetic instability-a calculated mechanism underlying tumor progression. J. Mol. Med. 2007, 85:139-148.
19. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2009, 59:225-249.
20. Kang M.J., et al. Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer. Res. 2011, 31:575-584.
21. Kasuya K., et al. Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. Oncol. Rep. 2011, 26:1399-1406.
22. Kim H.O., Jo Y.H., Lee J., Lee S.S., Yoon K.S. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol. Rep. 2008, 20:1181-1187.
23. Kim Y.H., et al. Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer. Int. J. Gynecol. Cancer 2011, 21:2-7.
24. Knechtel G., et al. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol. Carcinog. 2010, 49:805-809.
25. Konac E., Onen H.I., Metindir J., Alp E., Biri A.A., Ekmekci A. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect. Prev. 2007, 32:102-109.
26. Koshiji M., et al. HIF-1alpha induces genetic instability by transcriptionally down regulating MutSalpha expression. Mol. Cell. 2005, 17:793-803.
27. Koukourakis M.I., et al. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 2001, 61:1830-1832.
28. Koukourakis M.I., et al. C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer. Lung Cancer 2006, 53:257-562.
29. Koukourakis M.I., et al. Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci. 2006, 97:1056-1060.
30. Kuwai T., Kitadai Y., Tanaka S., Hiyama T., Tanimoto K., Chayama K. Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci. 2004, 95:149-153.
31. Lee J.Y., et al. Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin. Chim. Acta 2008, 389:167-170.
32. Li H., et al. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 2007, 67:1354-1361.
33. Li K., Zhang Y., Dan Z., Wang Y., Ren Z.C. Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans. Biochem. Genet. 2009, 47:625-634.
34. Ling T.S., Shi R.H., Zhang G.X., Zhu H., Yu L.Z., Ding X.F. Common single nucleotide polymorphism of hypoxia-inducible factor-1 alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin. J. Dig. Dis. 2005, 6:155-158.
35. Meng A.X., et al. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother. Oncol. 2005, 76:168-176.
36. Muñoz-Guerra M.F., Fernández-Contreras M.E., Moreno A.L., Martín I.D., Herráez B., Gamallo C. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann. Surg. Oncol. 2009, 16:2351-2358.
37. Ollerenshaw M., Page T., Hammonds J., Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet. Cytogenet. 2004, 153:122-126.
38. Orr-Urtreger A., Bar-Shira A., Matzkin H., Mabjeesh N.J. The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer. Prostate 2007, 67:8-13.
39. Ruan K., Song G., Ouyang G. Role of hypoxia in the hallmarks of human cancer. J. Cell. Biochem. 2009, 107:1053-1062.
40. Schmid T., Zhou J., Brune B. HIF-1 and p53: communication of transcription factors under hypoxia. J. Cell Mol. Med. 2004, 8:423-431.
41. Schneider B.P., et al. Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes. Breast Cancer Res. Treat. 2009, 116:543-549.
42. Semenza G.L. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 2000, 59:47-53.
43. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
44. Shieh T.M., et al. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol. 2010, 146:47-53.
45. Smaldone M.C., Maranchie J.K. Clinical implications of hypoxia inducible factor in renal cell carcinoma. Urol. Oncol. 2009, 27:238-245.
46. Szkandera J., et al. Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis. Anticancer. Res. 2010, 30:2393-2397.
47. Talks K.L., et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 2000, 157:411-421.
48. Tanimoto K., et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003, 24:1779-1783.
49. Tzao C., et al. Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis. Markers 2008, 25:141-148.
50. Wright M.E., et al. Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Res. 2009, 69:1429-1438.
51. Xu G., Wang M., Xie W., Bai X. Hypoxia-inducible factor-1 alpha C1772T gene polymorphism and glioma risk: a hospital-based case-control study from China. Genet. Test. Mol. Biomark. 2011, 15:461-464.
52. Yong D., et al. Association of uteroglobin G38A polymorphism with IgA nephropathy: a meta-analysis. Am. J. Kidney Dis. 2006, 48:1-7.
53. Zhao T., Lv J., Zhao J., Nzekebaloudou M. Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis. J. Exp. Clin. Cancer Res. 2009, 27:128-159.
54. Zheng Z.L., et al. Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients. Nephron Clin. Pract. 2009, 113:104-111.
55. Zhong H., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59:5830-5835.